Malignant Vulvar Neoplasm — Trials

Malignant Vulvar Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

184 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 54
Recruiting: 32
Ph III recruiting: 1
Growth YoY: —
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 21.3%
Trials / 1,000 deaths: 36.6 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (14)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02140021	Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer	terminated	N/A	409	M.D. Anderson Cancer CenterOTHER	1	Jul 14, 2025	clinicaltrials
NCT04105465	Study to Evaluate the Role of PlasmaJet in Patients Undergoing Groin Node Dissection for Vulval Cancer	terminated	N/A	21	Royal Surrey County Hospital NHS Foundation TrustOTHER	1	Sep 27, 2019